Work

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Year: 2006

Type: article

Source: Blood

DOI: 10.1182/blood.v108.11.2694.2694

Authors: Amy D. Klion, Marc E. Rothenberg, John J. Murray, Anish Singh, Hans-Uwe Simon

Institutions: National Institutes of Health, Cincinnati Children's Hospital Medical Center, Vanderbilt University, Sir Charles Gairdner Hospital, University of Bern

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2575284146

FWCI: 0.199

Cites:

Cited by: 2

Related to: 10